Literature DB >> 12829785

Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.

Martin J Boulanger1, Dar-chone Chow, Elena E Brevnova, K Christopher Garcia.   

Abstract

Interleukin-6 (IL-6) is an immunoregulatory cytokine that activates a cell-surface signaling assembly composed of IL-6, the IL-6 alpha-receptor (IL-6Ralpha), and the shared signaling receptor gp130. The 3.65 angstrom-resolution structure of the extracellular signaling complex reveals a hexameric, interlocking assembly mediated by a total of 10 symmetry-related, thermodynamically coupled interfaces. Assembly of the hexameric complex occurs sequentially: IL-6 is first engaged by IL-6Ralpha and then presented to gp130in the proper geometry to facilitate a cooperative transition into the high-affinity, signaling-competent hexamer. The quaternary structures of other IL-6/IL-12 family signaling complexes are likely constructed by means of a similar topological blueprint.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829785     DOI: 10.1126/science.1083901

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  209 in total

Review 1.  Cytokine homologs of human gammaherpesviruses.

Authors:  Sang-Hoon Sin; Dirk P Dittmer
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

2.  IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.

Authors:  Johan Nilvebrant; D Cameron Dunlop; Aroop Sircar; Thierry Wurch; Emilia Falkowska; Janice M Reichert; Gustavo Helguera; Emily C Piccione; Simon Brack; Sven Berger
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  Human herpesvirus 8-encoded cytokines.

Authors:  John Nicholas
Journal:  Future Virol       Date:  2010-03       Impact factor: 1.831

4.  Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes.

Authors:  Yibin Xu; Nadia J Kershaw; Cindy S Luo; Priscilla Soo; Michael J Pocock; Peter E Czabotar; Douglas J Hilton; Nicos A Nicola; Thomas P J Garrett; Jian-Guo Zhang
Journal:  J Biol Chem       Date:  2010-05-20       Impact factor: 5.157

5.  The composition and signaling of the IL-35 receptor are unconventional.

Authors:  Lauren W Collison; Greg M Delgoffe; Clifford S Guy; Kate M Vignali; Vandana Chaturvedi; DeLisa Fairweather; Abhay R Satoskar; K Christopher Garcia; Christopher A Hunter; Charles G Drake; Peter J Murray; Dario A A Vignali
Journal:  Nat Immunol       Date:  2012-02-05       Impact factor: 25.606

6.  A high-affinity protein binder that blocks the IL-6/STAT3 signaling pathway effectively suppresses non-small cell lung cancer.

Authors:  Joong-Jae Lee; Hyun Jung Kim; Chul-Su Yang; Hyun-Ho Kyeong; Jung-Min Choi; Da-Eun Hwang; Jae-Min Yuk; Keunwan Park; Yu Jung Kim; Seung-Goo Lee; Dongsup Kim; Eun-Kyeong Jo; Hae-Kap Cheong; Hak-Sung Kim
Journal:  Mol Ther       Date:  2014-03-31       Impact factor: 11.454

7.  RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.

Authors:  Florian Mittelberger; Cindy Meyer; Georg H Waetzig; Martin Zacharias; Erica Valentini; Dmitri I Svergun; Katharina Berg; Inken Lorenzen; Joachim Grötzinger; Stefan Rose-John; Ulrich Hahn
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 8.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

Review 9.  Interleukin-6 blockade in ocular inflammatory diseases.

Authors:  M Mesquida; A Leszczynska; V Llorenç; A Adán
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

10.  Conformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formation.

Authors:  Philip W Addis; Catherine J Hall; Shaun Bruton; Vaclav Veverka; Ian C Wilkinson; Frederick W Muskett; Philip S Renshaw; Christine E Prosser; Bruce Carrington; Alastair D G Lawson; Robert Griffin; Richard J Taylor; Lorna C Waters; Alistair J Henry; Mark D Carr
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.